Helen E. Scott
Impact in
-
- Prostate Cancer Treatment and Research
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 8
- Surgery 4
- Bladder and Urothelial Cancer Treatments 4
- Co-authors
- Anne Yvonne Warren (7 shared papers)David E. Neal (9 shared papers)Ian Geoffrey Mills (8 shared papers)Charles E. Massie (4 shared papers)Rory Stark (4 shared papers)Naomi L. Sharma (3 shared papers)Alastair D.G. Lamb (3 shared papers)Antonio Ramos‐Montoya (3 shared papers)
- Journals
- The EMBO Journal (2 papers)Clinical Cancer Research (2 papers)BMC Cancer (1 paper)Molecular Cancer Therapeutics (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United KingdomNorwayUnited States
In The Last Decade
Helen E. Scott
17 papers receiving 1.2k citations
Helen E. Scott's Hit Papers
Peers
Comparison fields: 5 of 62
- Pulmonary and Respiratory Medicine 724
- Cancer Research 218
- Molecular Biology 296
- Oncology 85
- Reproductive Medicine 18
Countries citing papers authored by Helen E. Scott
This map shows the geographic impact of Helen E. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Scott more than expected).
Fields of papers citing papers by Helen E. Scott
This network shows the impact of papers produced by Helen E. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Scott. The network helps show where Helen E. Scott may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen E. Scott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis Hit paper breakdown → | 2011 | 536 |
| 2 | 2012 | 330 | |
| 3 | 2014 | 68 | |
| 4 | 2014 | 55 | |
| 5 | 2008 | 33 | |
| 6 | 2014 | 33 | |
| 7 | 2017 | 33 | |
| 8 | 2020 | 32 | |
| 9 | 2019 | 31 | |
| 10 | 2020 | 31 | |
| 11 | 2008 | 29 | |
| 12 | 2014 | 18 | |
| 13 | 2008 | 14 | |
| 14 | 2022 | 7 | |
| 15 | Up-regulation of Flotillin 2 is associated with urothelial cell carcinoma progression | 2008 | 1 |
| 16 | C-MYC induction of HES6 activates a distinct transcriptional network driving androgen insensitive prostate cancer | 2011 | 1 |
| 17 | 2025 | 1 |
About Helen E. Scott
Helen E. Scott is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Neurology, Genetics and Cancer Research, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer, Hypoxia, and Metabolism (1 paper), Epigenetics and DNA Methylation (1 paper), Microtubule and mitosis dynamics (1 paper), Immune cells in cancer (1 paper), Alzheimer's disease research and treatments (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (724 citations), Cancer Research (218 citations), Molecular Biology (296 citations), Oncology (85 citations) and Reproductive Medicine (18 citations). Helen E. Scott has collaborated with scholars based in United Kingdom, Norway and United States. Frequent co-authors include Anne Yvonne Warren, David E. Neal, Ian Geoffrey Mills, Charles E. Massie, Rory Stark, Naomi L. Sharma, Alastair D.G. Lamb, Antonio Ramos‐Montoya, Vincent Roberto Zecchini and Stewart MacArthur. Their work appears in journals such as The EMBO Journal, Clinical Cancer Research, BMC Cancer, Molecular Cancer Therapeutics and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.